Gastrointestinal symptoms are common in human immunodeficiency virus (HIV)-infected patients with advanced stages of HIV infection (15, 20-22, 27, 30) . In a majority of patients with gastrointestinal diseases, opportunistic infectious agents can be identified; however, in a significant number of cases the etiology of diarrhea remains unexplained (3, 5, 12, 37) . It has been suggested that HIV itself might play a role in the pathogenesis of diarrhea by infecting cells of the intestinal mucosa (11, 29, 38, 44, 46) . This hypothesis is supported by in vitro studies in which a pathological effect of HIV on cultured epithelial cells of the intestinal mucosa was observed (1, 4, 16) . Moreover, in vivo infection by HIV of intestinal mucosal cells has been identified by in situ hybridization, PCR, and cell culture (18, 23, 25, 28, 32, 33, 35, 45) . Characterization of HIV type 1 (HIV-1) isolates recovered from the bowel showed that the biological and serological properties of these strains can differ from those of HIV-1 strains recovered from serum (2) .
Until now studies on HIV infection of intestinal cells in vivo are limited to those of cells in intestinal biopsy specimens. A longitudinal study at different stages of HIV-1 infection is needed to determine whether the mere presence of HIV-1 in the intestine is linked to the onset of gastrointestinal symptoms. However, for ethical reasons, intestinal biopsy specimens are difficult to collect from patients at different stages of disease, particularly at the asymptomatic stage. In vitro studies have shown that following HIV-1 infection, bowel epithelial carcinoma cells excrete viral particles at both the apical and basolateral surfaces of the cell, indicating that virus might be detectable in feces (17, 48) . Longitudinal collection of fecal specimens is easy and noninvasive. Therefore, feces is a suitable specimen from which viral nucleic acids that could have been produced in the gastrointestinal tract can be isolated and characterized.
Purification of viral RNA from feces is difficult by the most common extraction methods known to date, presumably because of its extremely varying composition. We have previously reported on a reliable and rapid procedure for the purification of nucleic acids from clinical specimens like serum and urine (6, 7) . This procedure is based on the lysing and nucleaseinactivating properties of the chaotropic agent guanidinium thiocyanate (GuSCN) and the concurrent binding of all nucleic acid types (DNA and RNA, both single and double stranded) by silica particles in the presence of this agent. In this report we describe a simple though effective modification of the basic procedure for the purification of HIV-1 RNA from fecal specimens. We validated the method in reconstruction experiments in which fecal specimens which strongly varied in color and consistency were spiked with HIV-1. These experiments revealed that the detection of HIV-1 RNA is not considerably influenced by the fecal composition.
Fecal specimens from 18 HIV-1-infected individuals were tested for the presence of HIV-1 nucleic acids. HIV-1 RNA could be detected in the feces of 12 individuals (67%). The specificities of the PCR products were confirmed by direct sequencing. To determine whether the sequences present in feces originated from blood leakage into the intestine or represent a distinct subpopulation, amplified HIV-1 RNA from corresponding serum samples was sequenced.
MATERIALS AND METHODS
Subjects. One or two fecal specimens were collected from 18 HIV-1-infected individuals (the characteristics of the individuals in the study group are given in Table 1 ). Two individuals (A and B) participated in a longitudinal cohort study among homosexual men (14) . Fecal and serum specimens were collected at the beginning of a study performed in 1984, when the patients were diagnosed as having CDC class II HIV infection (9) . Fecal and serum specimens were also obtained from these two individuals 9 years later. During this period individual A developed AIDS and individual B showed persistent generalized lymphadenopathy (CDC class III). One male (individual C) presented in the clinic with acute HIV-1 infection (lymphadenopathy, fever, exanthema, HIV-1 p24 present in serum, no detectable antibodies to HIV-1). Fecal and serum specimens were collected 3 weeks later, at which time the individual was asymptomatic and antibodies directed to p24, p55, and gp120/gp160 could be measured by Western blotting (immunoblotting; HIV blot 2.2; Diagnostic Laboratories); therefore, individual C was clinically staged at group CDC class II. A second fecal specimen was collected 8 months later. Individuals D to R presented in the clinic, and 13 of them were diagnosed with AIDS. Two fecal and serum specimens were collected from individual D within 3 months. Eight individuals in the study suffered from diarrhea at the time of fecal sampling. An opportunistic infection could be identified in a majority of these individuals: cryptosporidial infection in three individuals (individuals E, K, and N), microsporidial infection in one individual (individual O), and a gastrointestinal infection by adenovirus in one person (individual F). No pathogen could be identified as causative agent of diarrhea in individuals H and R. Individual I suffered from a mild diarrhea at the time of fecal sampling, and tests for enteric pathogens were not performed. Sixteen participants were males infected by homosexual contact; individual M was a male infected by intravenous drug use, and individual N was a woman who became infected by heterosexual contact with an intravenous drug user. The detection of HIV-1 RNA in feces and serum was performed with the informed consent of all persons.
Reconstruction experiments. The serum of an HIV-1-infected person with a known quantity of virus was used as a control for the reconstruction experiments. The quantity of virus in this serum specimen was measured by limiting dilution of the serum in a nested gag reverse transcription PCR (RT-PCR) with SK39, SK145, SK431, and SK102 primers (26, 36) . The quantification method was validated with a virus preparation in which the particle counts had been quantified directly by electron microscopy (31) . The concentration of viral RNA in the serum which was used in the reconstruction was 1 ϫ 10 7 HIV-1 RNA molecules per ml of serum (5 ϫ 10 6 virions per ml of serum), and 10 l of a 10-fold dilution (containing 1 ϫ 10 4 HIV-1 RNA molecules) in sterile H 2 O was used to spike fecal specimens. To determine the efficiency of extraction of HIV-1 RNA from fecal specimens, 17 fecal samples of various colors and consistencies which were negative for HIV-1 RNA were used. One fecal specimen from an HIV-1-seronegative person was used in an experiment to monitor the stability of HIV-1 RNA during repeated freezing-thawing. Approximately 30% (vol/vol) suspensions were made from fecal specimens by mixing them with broth (containing nutrient broth no. 2 supplied by Oxoid, 500 IU of penicillin per ml, 500 g of streptomycin per ml, and 3 g of amphotericin B per ml). For one fecal specimen a 30% (vol/vol) suspension was made by mixing it with 40% glycerol. This suspension was used for the comparison of different extraction techniques. Glycerol was added to this fecal specimen to preserve bacterial integrity upon storage at Ϫ20ЊC.
Storage of patient specimens. Fecal specimens collected in 1984 were suspended in broth and were stored at Ϫ70ЊC. Fecal specimens collected in 1993 and 1994 were stored as lysates in two ways: (i) feces was mixed with broth (30% [vol/vol]; see above) and subsequently, 100 l of the suspension was added to 1,200 l of L 6 lysis buffer (7) or (ii) approximately 50 mg of feces was added directly to 1,200 l of L 6 lysis buffer. Lysates were stored at Ϫ20ЊC. Serum samples were stored at Ϫ70ЊC.
Extraction of RNA from feces and serum. (i) Protocol Y/SC. Isolation of nucleic acids from serum specimens was performed by protocol Y/SC (7). Briefly, 100 l of serum was added to a tube containing 900 l of L 6 lysis buffer (see below) and 40 l of silica suspension. The tube was immediately vortexed. During an incubation of 10 min at room temperature, the RNA in the specimens was allowed to complex with the silica particles. The tubes were subsequently vortexed again and centrifuged for 15 s at 10,000 rpm (24-hole Hettich KG centrifuge), the supernatant was discarded, and the silica-nucleic acid complexes were washed twice with 1 ml of buffer L 2 (see below), twice with 1 ml of 70% (vol/vol) ethanol, and once with 1 ml of acetone and were dried at 56ЊC (10 min); the nucleic acids were then eluted at 56ЊC (10 min) in 60 l of sterile H 2 O. Twenty microliters of the eluate was used in an RT reaction, and 20 l of eluate was used for the negative control reaction without reverse transcriptase.
The preparation of size-fractionated silica, lysis buffer L 6 , and wash buffer L 2 has been described in detail by Boom et al. (7) . In short, lysis buffer L 6 was made by dissolving 120 g of GuSCN in 100 ml of 0.1 M Tris ⅐ HCl (pH 6.4), and subsequently, 22 ml of 0.2 M EDTA (pH 8.0) and 2.6 g of Triton X-100 were added. Washing buffer L 2 was made by dissolving 120 g of GuSCN in 100 ml of 0.1 M Tris ⅐ HCl (pH 6.4).
(ii) Protocol F/SC. Nucleic acids were extracted from the feces-broth mixtures by protocol F/SC, which is a slightly modified version of protocol Y/SC. In short, fecal specimens previously lysed in L 6 buffer and stored at Ϫ20ЊC were thawed, or 50 to 100 l of the feces-broth mixture was added to 1,200 l of lysis buffer L 6 and the mixture was vortexed vigorously. After 10 min at room temperature, the tubes were centrifuged (3 min at 10,000 rpm [24-hole Hettich KG centrifuge]). The resulting supernatant is free of particulate debris which would otherwise cosediment with silica-nucleic acid complexes when the standard protocol (pro- tocol Y/SC) described above would have been used. Nine hundred microliters of the supernatant was then added to 40 l of silica suspension and was immediately vortexed, and the nucleic acids were allowed to bind during incubation for 10 min at room temperature. The tube was subsequently vortexed again and centrifuged for 15 s at 10,000 rpm (24-hole Hettich KG centrifuge). The supernatant was discarded and the silica-nucleic acid complexes were washed, dried, and eluted as described above for protocol Y/SC. In an isolated experiment an input of 1 ml of fecal suspension which was lysed in 9 ml of L 6 was used. Following centrifugation, 9 ml of supernatant was added to 40 l of the silica suspension, and the tube was vortexed, incubated for 10 min at room temperature, and vortexed again. After centrifugation for 20 min at 3,000 rpm (Rotanta/AP Hettich centrifuge) the supernatant was discarded and the nucleic acids were purified as described above. In experiments in which the stability of rRNA during extraction was monitored 100 l of thawed feces-glycerol mixture lysed in 1 ml of L 6 was used. In these particular experiments nucleic acids were eluted in 80 l of TE containing an inhibitor of RNases (20 mM ribonucleoside-vanadyl complexes [RVCs]; Sigma).
(iii) Proteinase K-SDS procedure. One hundred microliters of a thawed fecesglycerol mixture was lysed by adding 100 l of lysis buffer containing 250 mM Tris (pH 7.5), 250 mM EDTA (pH 7.5), 1% sodium dodecyl sulfate (SDS), and 500 g of proteinase K (Sigma) per ml. After an incubation for 1 h at 56ЊC, the samples were extracted twice with phenol-chloroform-isoamyl alcohol (25:24:1) and once with chloroform-isoamyl alcohol (24:1), and the nucleic acids were precipitated by adding 2.5 volumes of ethanol (100%) in the presence of 0.1 M NaCl. The nucleic acids were washed with 70% ethanol and were redissolved in 80 l of TE containing 20 mM RVCs.
RT. Annealing of the primer with template RNA was performed in a mixture containing 16 (39) . After annealing for 3 min at room temperature, 200 U of Superscript (BRL GIBCO) and MgCl 2 (to a final concentration of 6 mM) were added and RT was performed for 1 h at 37ЊC in a total volume of 40 l. Reverse transcriptase was denatured by incubation for 5 min at 95ЊC (40) , and RNase H treatment was performed for 30 min at 37ЊC with 0.5 U of RNase H (Boehringer). As a control, reactions without reverse transcriptase were performed as described for the RT reaction but without the addition of Superscript and RNAsin and without the RNase H treatment.
PCR. Twenty microliters of cDNA was added to 80 l of the PCR mixture containing 100 ng of antisense primer (L9, 5Ј-CCCAAGGAACAAAGCTCC-3Ј; nucleotides 7787 to 7804 [HIV-1 MN ]), 100 ng of sense primer (5Ј V3NOT; 5Ј-GCGCGGCCGCACAGTACAATGTACACATGG-3Ј; nucleotides 6983 to 7002 [HIV-1 MN ]), 62.5 mM Tris (pH 8.3), 25 mM KCl, 0.125 mg of BSA per ml, 125 M (each) dNTPs, 1.25 mM MgCl 2 , and 2 U of Taq polymerase (PerkinElmer Cetus). After incubation for 5 min at 94ЊC the sample was subjected to 35 cycles of amplification in a DNA thermal cycler (type 480; Perkin-Elmer Cetus). A cycle consisted of denaturation for 15 s at 94ЊC, annealing for 45 s at 55ЊC, and extension for 1 min at 72ЊC. After the cycling program the samples were incubated for 10 min at 72ЊC. Five microliters of the first PCR mixture was amplified in a nested PCR of 30 cycles in 100 l containing 100 ng of antisense primer (3ЈV3NOT; 5Ј-GCGCGGCCGCCCCCTCTACAATTAAAACTGTG-3Ј; nucleotides 7367 to 7388 [HIV-1 MN ]), 100 ng of sense primer (5ЈKSI, 5Ј-ATAAGCT TGCAGTCTAGCAGAAGAAGA-3Ј; nucleotides 7041 to 7059 [HIV-1 MN ]), 50 mM Tris (pH 8.3), 20 mM KCl, 0.1 mg of BSA per ml, 100 M (each) dNTPs, 2 mM MgCl 2 , and 2 U of Taq polymerase (Perkin-Elmer Cetus). The same cycle program used for the first PCR was performed. In reconstruction experiments a single PCR was used, and 37 cycles of amplification were performed. Ten microliters of the amplified product was analyzed by agarose gel electrophoresis. PCR products derived from the stability and efficiency tests (a single PCR) were detected after Southern blotting by hybridization with a 32 P-labeled probe made from a plasmid containing the entire gp160 of HIV-1 MN (plasmid KL-8; see below). The PCR product of the nested PCR was detected by ethidium bromide staining of an agarose gel. Negative and positive extraction controls were included in each experiment. As a positive control, 10 5 HIV-1 RNA molecules isolated from a virus culture were used (31) .
To construct the gp160-containing plasmid, a PCR was performed on chromosomal DNA containing HIV-1 MN proviral DNA with the primers VIF-N (5Ј-GATGCGGCCGCTCGCGATTATGGAAAACAGANGGCAGGTG ATGATTGTG 3Ј; nucleotides 5054 to 5085 [HIV-1 MN ]) and 3Ј END-N (5Ј-GA GGCGGCCGCGGCAAGCTTTATTGAGGCTTAAG 3Ј; nucleotides 9621 to 9643 [ HIV-1 MN ] ). This PCR product was cloned into plasmid PSP73 (Promega) and was subsequently subcloned in PSP64polyA (Promega). The final plasmid, KL-8, contained gp160 of HIV-1 MN from nucleotides 5758 to 8917. Underlining in the primers indicates endonuclease restriction sites.
Sequencing. Ten microliters of the nested PCR product was purified from a neutral agarose gel by dissolving approximately 50 l of a gel slice in 900 l of lysis buffer L 7 T (containing 1 mg of casein [purified from bovine milk; catalog no. C5890 Sigma]) per ml of L 6 ) and 2.5 l of the silica suspension. The tubes were vortexed every 10 min during incubation for 40 min at 37ЊC. DNA-silica complexes were washed twice with 1 ml of L 2 , twice with 1 ml of 70% ethanol, and once with 1 ml of acetone. After drying at 56ЊC for 10 min the purified DNA was eluted at 56ЊC (10 min) in 15 l of TE, and 6 l of purified DNA was used in a sequence reaction. Both strands were sequenced by using the sense primer 5ЈPVUII-J (5Ј-GTACAGCTGAATGAATCTGTAGAAATTAATTGT-3Ј; nucleotides 7102 to 7126 [HIV-1 MN ]) and the antisense primer 3ЈV3NOT. In the presence of one of the sequence primers the PCR product was denatured by incubating for 3 min at 100ЊC; this was followed by immediate freezing at Ϫ78ЊC in dry ice with ethanol. Dideoxynucleotide sequencing was performed by using Sequenase 2.0 (U.S. Biochemicals) by applying the following modifications to the manufacturer's protocol. Labeling reactions with [
35 S]dATP and termination reactions were performed simultaneously at 37ЊC for 5 min in the presence of 10% dimethyl sulfoxide.
Nucleotide sequence accession numbers. The sequences presented in this report have been submitted to GenBank (accession no. L38720-L38733).
RESULTS
Adaptation of standard protocol Y/SC for feces. A serious drawback for the isolation of RNA from feces is the presence of very high concentrations of RNases. To address this issue, a recently described nucleic acid extraction technique was used (7). The technique efficiently inactivates RNases during lysis of the sample (protocol Y/SC). However, to isolate nucleic acids from crude feces or feces-broth mixtures an adaptation of the standard procedure for extraction appeared to be necessary, since preliminary experiments showed that debris which cosedimented with silica-nucleic acid complexes caused RNA degradation (data not shown). To overcome this problem we included a centrifugation step which removed debris from the lysate prior to binding of nucleic acids to silica particles (protocol F/SC).
Inactivation of RNases during nucleic acid extraction. RNA isolation from feces by protocol F/SC was compared with the isolation of RNA by a classic method that uses proteinase K-SDS-mediated lysis and several extractions with organic solvents. The integrity of bacterial rRNA was used as a marker for the inactivation of RNases in the different purification procedures. The nucleic acids isolated by the two different methods were examined by agarose gel electrophoresis and ethidium bromide staining. In Fig. 1 the degradation of rRNA extracted from feces by the classic procedure is apparent, while the rRNA isolated by protocol F/SC remained intact.
Efficiency of RNA extraction and RT-PCR from feces. The influence of the composition of feces on the extraction and the detection technique was monitored for 17 different fecal specimens. Virions (5 ϫ 10 3 ) were added to 50 l of feces-broth mixtures, and the nucleic acids were purified by protocol F/SC. FIG. 1. Purified nucleic acids from feces isolated by different extraction techniques. Thirty microliters of nucleic acids which were purified from a fecesglycerol suspension was electrophoresed through a 0.8% agarose gel containing ethidium bromide, and the gel was subsequently photographed under UV illumination. Lanes 1 and 7, 2 g of phage lambda DNA digested with HindIII; lanes 2 and 8, 2 g of Escherichia coli rRNA; lanes 3 and 4, nucleic acids purified by the proteinase K-SDS procedure; lanes 5 and 6, nucleic acids purified by protocol F/SC. The photograph was scanned by using a Scanjet IIC scanner (HewlettPackard), the layout was done with MacDrawPro 1.5 (Claris Corporation), and the picture was printed on a Kodak Colorease PS printer.
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In parallel, nucleic acids were purified from positive (5 ϫ 10 3 virions in H 2 O) and negative (no HIV added) samples. Following extraction, HIV-1 RNA was amplified by a single RT-PCR and the PCR products were analyzed by Southern blot hybridization (Fig. 2) . In all specimens the input HIV-1 RNA was amplified, albeit to a different extent. The variation between duplicates could have been due to the small number of spiked virions, which was close to the lower limit of detection (see below). A comparable experiment was performed on seven fecal samples with an input of 100 l of feces-broth suspension. Again, from all fecal specimens the spiked input of 5 ϫ 10 3 virions could be amplified in a single PCR (data not shown).
The lower limit of detection was determined for two fecal specimens (specimens F9 and F12 in Fig. 2 ). To determine whether the variability of the PCR signal as shown in Fig. 2 was the result of inefficient amplification in a single PCR or inefficient extraction, fecal specimen F9 was included in the experiment since specimen F9 clearly exhibited a diminished signal in the single PCR. Twofold serial dilutions of virus were added to 50 l of the feces-broth mixtures of specimens F9 and F12. Nucleic acids were extracted by protocol F/SC, and the detection level was determined in two ways: in a single PCR, in conjunction with detection by Southern blot hybridization, and in a nested PCR, with product detection by ethidium bromide agarose gel electrophoresis. The lowest concentration of virus which could be amplified and monitored was equal for a single PCR and a nested PCR and was 300 virions (600 HIV-1 RNA molecules) in both fecal specimens (data not shown). The detection level turned out to be the same for both fecal specimens, indicating that the variability seen in a single PCR (Fig.  2) is most likely the result of a feces-dependent variable amplification efficiency in a single PCR and not an effect of inefficient extraction of the viral RNA.
Stability of HIV-1 RNA in feces upon freezing-thawing. The stability of virus during repeated freezing-thawing was monitored in a reconstruction experiment for one fecal specimen. To 600 l of feces-broth mixture, 3 ϫ 10 4 virions were added. This mixture was freeze-thawed four times. One freeze-thaw cycle included contact for 5 min with dry ice (Ϫ78ЊC) and incubation at room temperature until the specimen was thawed. Before each cycle of freezing, 100 l of the mixture was added to 1 ml of L 6 . After extraction of nucleic acids and amplification by a single RT-PCR the amplified products were detected by Southern blot hybridization. The PCR signals obtained after each freezing-thawing cycle are shown in Fig. 3 . The signal obtained after four cycles of freezing-thawing was equal to the signal obtained with the samples which were not frozen, indicating that RNA molecules within virions were not degraded during repeated freezing-thawing.
Detection of HIV-1 RNA in feces of HIV-1-infected individuals. Twenty-two fecal specimens from 18 HIV-1-infected individuals were tested for the presence of HIV-1 RNA. In 1993 to 1994 three of the individuals fulfilled the criteria for CDC class II, one fulfilled the criteria for CDC class III, and 14 were diagnosed with AIDS (Table 1) . HIV-1 RNA could be detected in the feces of 12 of the 18 individuals (67%) with an input of either 100 l of a fecal suspension or approximately 50 mg of feces (Table 1 and Fig. 4) . HIV-1 RNA was detected in the feces of two of the three persons belonging to CDC class II (individuals C and F), among which was one individual who had recently been infected. HIV-1 RNA was also detected in the feces of the one person (individual B) who was clinically classified in CDC class III. Furthermore, HIV-1 RNA was present in the feces of 9 of the 14 individuals who were diagnosed with AIDS (individuals A, D, E, G, H, I, N, O, and R).
Two fecal specimens were collected from four individuals at different times. A second fecal specimen was collected 8 months later from the person whose fecal specimen was obtained a few weeks after primary infection (individual C). In this specimen HIV-1 RNA was again detectable. Furthermore, a second fecal specimen from one of the persons with AIDS (individual D), which was collected 3 months after the first specimen was obtained, was again positive for HIV-1 RNA. Fecal samples had also been collected from two individuals (individuals A and B) 9 years earlier. At that time both persons were asymptomatic and fulfilled the criteria for CDC class II. P-labeled gp160-containing plasmid probe. Lanes C1 to C4, amplified control input HIV-1 RNA; lanes f1 to f17, amplified HIV-1 RNA extracted from 17 different fecal specimens; lane N1, negative extraction control in the extraction series containing C1, C2, and f1 to f8; lane N2, negative extraction control in the extraction series containing C3, C4, and f9 to f17. The picture was scanned as described in the legend to Fig. 1.   FIG. 3 . Stability of virions during freezing-thawing. A fecal suspension was spiked with virions and freeze-thawed several times, and nucleic acids were extracted and amplified in a single PCR. Ten microliters of PCR product was electrophoresed on a 1% agarose gel, blotted onto nitrocellulose, and hybridized with a 32 P-labeled gp160-containing plasmid probe. Lane 1, PCR product without freezing-thawing of the sample; lanes 2 to 5, PCR product after one to four cycles of freezing-thawing, respectively; lane 6, PCR product of spiked fecal suspension which was incubated at room temperature for 1 h, lane 7, negative extraction control. The picture was scanned as described in the legend to Fig. 1 HIV-1 RNA could also be extracted and amplified from these early specimens. For all fecal specimens the reaction without reverse transcriptase was negative, suggesting that the detected signals originated from HIV-1 RNA rather than from proviral DNA (data not shown).
With an input of 50 l of a fecal suspension, HIV-1 RNA could be detected in 9 of the 18 (50%) HIV-1-infected individuals ( Table 1 ), indicating that in three persons the amount of HIV-1 RNA in feces was close to the detection level. HIV-1 RNA could not be detected in feces from six HIV-1-infected individuals, while HIV-1 RNA was detectable in their sera (Table 1 ). This indicates that the primers used in the RT-PCR bound to the viral RNA extracted from the sera of those persons. However, to ensure that inefficient annealing of the envelope primers to the viral RNA extracted from feces was not the cause of the negative results, a nested gag RT-PCR with primers SK39, SK145, SK431, and SK102 (26, 36) was also performed on nucleic acids extracted from the feces of the six individuals. The gag RT-PCR was not positive for any of the specimens (data not shown). In reconstruction experiments in which these six fecal specimens were spiked with virions (5 ϫ 10 3 ), this input was efficiently purified and amplified by RT-PCR (data not shown).
Negative and positive controls accompanied the clinical specimens in the extractions. In none of the experiments did these controls test either false positive or false negative.
Direct sequencing. The specificities of the PCR products from feces and serum were confirmed by direct sequencing of the amplimers. From 16 fecal specimens from the 12 persons in whose feces HIV-1 RNA was detectable, HIV-1 sequences confirmed the specificity of the nested RT-PCR product (data not shown). A comparison of the HIV-1 sequences obtained from eight paired fecal and serum specimens by direct sequencing revealed that the subpopulation of HIV-1 found in feces can differ from the HIV-1 subpopulation found in serum. In most cases the HIV-1 RNA sequence of virus from feces appeared to be more homogeneous than the sequence of virus from serum (individuals A [1984 and 1993] , B [1984 and 1993] , G, and H; Fig. 5B and 6 ). Although the sequence of virus from the feces of individual A (1993) was more homogeneous when the entire sequence of the V3 region was compared, there were some positions at which the sequence of virus from feces displayed heterogeneity whereas the sequence of virus from serum did not (Fig. 5A and 6 ). Sequences of virus from fecal and serum specimens which were obtained shortly after primary infection of individual C were identical (data not shown). Remarkably, the sequences of HIV-1 from feces and serum of individual I obtained by direct sequencing were clearly distinct (Fig. 5C) . Besides a codon deletion, some positions displayed different nucleotides. These nucleotide substitutions resulted in a different deduced amino acid sequence of the V3 loop (Fig. 7) . Since we analyzed both the sequences and the heterogeneities of the sequences of HIV-1 from feces and serum by direct sequencing of the PCR products, the reproducibility of direct sequencing was crucial. Therefore, duplicate extractions, amplifications, and direct sequencing of two serum samples was performed. Of the 220 nucleotides that were sequenced, a difference in heterogeneity was measured between the two duplicate sequences at only a single position, which was a very small percentage of the total heterogeneous nucleotide positions (3.2%) (data not shown). Furthermore, the effect of the input amount on the heterogeneity in a sequence determined by direct sequencing was examined. HIV-1 RNA was extracted from 1-ml and 100-l fecal suspensions of individual B (1993) and was then amplified. The sequence with 10 times more input did not result in a substantial change in the heterogeneity (0.9%) of the sequence (data not shown).
DISCUSSION
We have presented a rapid and simple method (protocol F/SC) for the purification of HIV-1 RNA from feces which is unique in its simplicity. HIV-1 RNA can easily be purified from large series of fecal specimens (12 specimens in about 1.5 h) and has appeared to be a good substrate in RT-PCR. The variability in the composition of fecal specimens did not seem to play a major role in the extraction of HIV-1 RNA. A nested RT-PCR instead of Southern blot hybridization of a single PCR was chosen for the detection of HIV-1 RNA because it is more rapid and the amplimers are produced in such quantities that they can be used for direct sequencing.
HIV-1 RNA has previously been detected in feces from HIV-1-infected children (49) . Our data extend these observations to HIV-1-infected adults. We could detect HIV-1 RNA in the feces of the majority (67%) of our study group. Among the individuals in whose feces HIV-1 RNA was detectable were individuals who were clinically staged in CDC classes II, III, and IV. So the detection of HIV-1 RNA was not restricted to those with a certain stage of HIV-induced disease.
In theory, the HIV-1 RNA detected in feces could be either RNA in HIV-1-infected cells or genomic HIV-1 RNA within viral particles. The HIV-1 RNA detected in feces probably originated from virions, because we did detect HIV-1 RNA in feces which had been stored for 9 years at Ϫ70ЊC. It is unlikely that cells could have survived these storage conditions, and , and C) ; ‫,ء‬ the sequence of virus from serum is heterogeneous, while the sequence of virus from feces is homogeneous at this position; F, the sequence of virus from serum is homogeneous, while the sequence of virus from feces is heterogeneous at this position; #, sites where sequences of virus from serum and feces display different nucleotides. Numbering is as described previously for HIV-1 MN (34) .
barrier because of the increased permeability of the epithelial cell layer (1, 4, 16, 21, 27) . Future research on the characterization of variants in different cell types in the intestinal mucosa is needed to determine the origins of HIV-1 particles in feces.
We can rigorously exclude the possibility that the high percentage of HIV-1 RNA-positive fecal specimens was the result of aspecific amplification or contamination in the PCR. In all experiments negative controls were added in the extraction, and they never turned out to be positive. Furthermore, in all amplifications from fecal and serum specimens the RT-PCR performed without reverse transcriptase was negative, indicating not only that the PCR signal originated from RNA but also that no contamination by PCR products or HIV-containing plasmids had occurred. Furthermore, the PCR products of the fecal specimens were sequenced, and this excluded the possibility of intersample contamination.
The nucleotide sequences showed a more homogeneous subpopulation of HIV-1 in feces in comparison with that in serum for a majority of the individuals studied. In principle, this decreased level of heterogeneity could be caused by the amplification of only a few molecules of HIV-1 RNA. However, in the one case studied a 10-fold increase in the amount of feces input did not result in a significant difference in the heterogeneity of the direct sequence.
At some positions in the HIV-1 RNA from feces the nucleotides displayed heterogeneity which was not detectable in serum, suggesting that a distinct HIV-1 subpopulation is present in feces. Moreover, in one case a clear-cut difference between the sequences of virus from feces and serum obtained by direct sequencing was observed. It is therefore unlikely that the presence of viral RNA in feces is solely the result of leakage from blood. Our characterization of HIV-1 variants in feces by direct sequencing confirms the findings of Barnett et al. (2) , who showed that HIV isolated from the bowel can differ in biological and serological properties from HIV strains in blood. The cell tropism of HIV-1 is dependent on the amino acid sequence of the envelope (8, 10, 13, 19, 41) , among which is the V3 region (24, 42, 43, 47) . The direct sequence of the V3 region of virus from individual I showed a deduced amino acid sequence which differed substantially from that of virus in serum. Therefore, it could be that the viruses detected in the feces of individual I are produced in a cell type different from the cells in the blood that produce virus.
In the study described here a relatively small group of HIV-1-infected patients was studied; therefore, a correlation between gastrointestinal symptoms and the detection of HIV-1 RNA cannot be made. In addition, most individuals in our study group were males infected by homosexual contact, and the chance that they were infected by passive anal sexual intercourse is great. Future research will reveal whether there is a link between the route of HIV-1 transmission and the presence of HIV-1 in the intestinal lumen and whether there is a link between the onset of gastrointestinal symptoms and the detection of HIV-1 RNA in feces.
